Search by Drug Name or NDC

NDC 55513-0954-01 Vectibix 100 mg/5mL Details

Vectibix 100 mg/5mL

Vectibix is a INTRAVENOUS SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amgen Inc. The primary component is PANITUMUMAB.

MedlinePlus Drug Summary

Panitumumab is used to treat a type of cancer of the colon or rectum that has spread to other areas of the body either during or after treatment with other chemotherapy drugs. Panitumumab is in a class of medications called monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

Related Packages: 55513-0954-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Panitumumab Injection

Product Information

NDC	55513-0954
Product ID	55513-954_59928d12-bde9-4433-8316-a142514ef952
Associated GPIs	21360070002025
GCN Sequence Number	064351
GCN Sequence Number Description	panitumumab VIAL 100 MG/5ML INTRAVEN
HIC3	V1W
HIC3 Description	ANTINEOPLASTIC EGF RECEPTOR BLOCKER MCLON ANTIBODY
GCN	13632
HICL Sequence Number	034054
HICL Sequence Number Description	PANITUMUMAB
Brand/Generic	Brand
Proprietary Name	Vectibix
Proprietary Name Suffix	n/a
Non-Proprietary Name	panitumumab
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	100
Active Ingredient Units	mg/5mL
Substance Name	PANITUMUMAB
Labeler Name	Amgen Inc
Pharmaceutical Class	Antibodies, Monoclonal [CS], Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	BLA
Application Number	BLA125147
Listing Certified Through	2024-12-31

Package

NDC 55513-0954-01 (55513095401)

Pricing Information	N/A
NDC Package Code	55513-954-01
Billing NDC	55513095401
Package	1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-01) / 5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date	2006-10-10
NDC Exclude Flag	N